MNV
Market News Video
MNV MNV 10 Bargains You Can Buy Cheaper Than Insiders Did
MNV
MNV
MNV
MNV
MNV
MNV
MNV
Free Dividend Report - Top Ranked Stocks

Featured MNV Articles:

Blueprint Medicines Becomes Oversold (BPMC)
Thursday, August 17, 4:24 PM ET, by Market News Video Staff

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy ...

WellCare Health Plans is Now Oversold (WCG)
Monday, August 28, 12:13 PM ET, by Market News Video Staff

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy ...

How The Parts Add Up: SMLF Headed For $39
Wednesday, August 30, 9:37 AM ET, by Market News Video Staff

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, ...

How The Pieces Add Up: PTH Headed For $72
Friday, September 8, 9:17 AM ET, by Market News Video Staff

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, ...

Noteworthy Thursday Option Activity: PCYG, ORCL, VNDA
Thursday, September 14, 11:33 AM ET, by Market News Video Staff

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume ...

  More articles:  1 2 next »

VNDA Makes Notable Cross Below Critical Moving Average

By Market News Video Staff, Monday, March 20, 4:29 PM ET
Play Video: Learn About The 200 DMA


If the video does not load after a few moments, Upgrade to the Latest Flash Player.

In trading on Monday, shares of Vanda Pharmaceuticals Inc (NASDAQ:VNDA) crossed below their 200 day moving average of $14.20, changing hands as low as $14.10 per share. Vanda Pharmaceuticals Inc shares are currently trading off about 1.4% on the day. The chart below shows the one year performance of VNDA shares, versus its 200 day moving average:

Vanda Pharmaceuticals Inc 200 Day Moving Average Chart

Looking at the chart above, VNDA's low point in its 52 week range is $7.20 per share, with $18.00 as the 52 week high point that compares with a last trade of $14.15.


Can your brain be trained to become a chart-predicting wizard? Click here to find out

According to the ETF Finder at ETF Channel, VNDA makes up 1.02% of the PowerShares DWA Healthcare Momentum Portfolio ETF (NASDAQ:PTH) which is trading lower by about 0.4% on the day Monday.

See what other ETFs contain VNDA
See what other stocks are held by PTH


Top Six Most Viewed Stories This Week @ Market News Video:

This Article's Word Cloud:   According   Click   Crossing   ETFs   Finder   Healthcare   Looking   Momentum   Monday   Pharmaceuticals   Portfolio   Start   Stocks   Their   VNDA   Vanda   about   average   below   brain   changing   chart   compares   contain   currently   find   hands   held   here   last   lower   makes   moving   other   point   predicting   range   raquo   share   shares   slideshow   that   trading   versus   week   what   which   with   year   your
MNV
MNV
About Us - Advertise - Contact Us - Embedding Videos - Licensing Videos - Partners - mRSS / RSS Feed - Terms of Use - Privacy Policy - Video Widget
MNV
Home  |  Analyst News  Dividend Report  ETFs  Insider Report  Large Caps  Market Movers  Week Ahead Report  Weekly Market Wrap
MNV
MNV MNV Portfolio Channel Stock Market Definitions
MNV

VNDA Makes Notable Cross Below Critical Moving Average | Market News Video | Copyright © 2008 - 2017, All Rights Reserved

Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners. In no way should any content contained herein be interpreted to represent trading or investment advice. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.